Delcath Systems (DCTH) Enters Launch, Training Agreement for CHEMOSAT with IGR

Delcath Systems, Inc. (Nasdaq: DCTH) has entered into an initial launch and training agreement for the Delcath Hepatic CHEMOSAT Delivery System with the Institut Gustave Roussy ("IGR"), a leading European cancer center located in Villejuif, France. Under the terms of the agreement, the Company will provide the IGR with logistics and clinical training support in chemosaturation therapy using the CHEMOSAT system. The Company expects training at the IGR to begin in April 2012. Upon completion of training, the IGR will be the first cancer center to commercially utilize the CHEMOSAT system to treat patients in France.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Boeing names Ryan Shedd as new SVP and controller
• Cytek faces $56M damages award in Beckman Coulter patent case
• Lazard Global Total Return fund declares $0.1534 monthly distribution